Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Skin Cancer
85%
Actinic Keratosis
76%
Protein P53
74%
Eflornithine
70%
Placebo
51%
Colon Cancer
43%
Malignant Neoplasm
37%
Overall Survival
35%
Skin Carcinogenesis
31%
Biological Product
31%
Pancreas Cancer
27%
Skin Carcinoma
26%
Non Melanoma Skin Cancer
26%
Mouse
26%
Clinical Trial
26%
Murine
26%
Melanoma
26%
Breast Cancer
25%
Heat Shock Protein
23%
Phosphotransferase
23%
Tocopherol
23%
Recurrence Risk
23%
Intraductal Carcinoma
23%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
23%
Perillyl Alcohol
23%
Gallstone
23%
Empyema
23%
Bile Leakage
23%
Rectum Carcinoma
23%
Rectum Cancer
23%
Histocompatibility Antigen
23%
Bile Salt
23%
Plasminogen Activator
23%
Serine
23%
Inositol Polyphosphate 5 Phosphatase
23%
Abdominal Wall Hernia
23%
Leriche Syndrome
23%
Prostaglandin Synthase
23%
Tissue Plasminogen Activator
23%
Pembrolizumab
23%
Diclofenac
23%
Lamin A
23%
Hypoxia
23%
Plasmid DNA
23%
Ornithine
23%
Lung Cancer
23%
Thioredoxin Reductase
23%
Thioredoxin
23%
Lobular Carcinoma
23%
Medicine and Dentistry
Surgery
73%
Nodular Melanoma
73%
Skin Cancer
60%
Protein P53
57%
Biological Marker
51%
Neoplasm
49%
Actinic Keratosis
49%
Metastatic Carcinoma
47%
Recurrent Disease
46%
Programmed Cell Death
43%
Protein Expression
38%
Skin Carcinoma
32%
Chemoprophylaxis
32%
Squamous Cell
31%
Rectum Carcinoma
30%
Colon Mucosa
28%
Signal Transduction
27%
Colon Cancer
27%
Radiation Therapy
26%
Biopsy
24%
Multivariate Analysis
23%
Perillyl Alcohol
23%
Rectum Cancer
23%
Intraductal Carcinoma
23%
Local Therapy
23%
Recurrence Risk
23%
Optical Coherence Tomography
23%
Sphincter
23%
Hypoxia
23%
Lung Metastasis
23%
Inositol Polyphosphate 5 Phosphatase
23%
Aortoiliac Occlusive Disease
23%
Abdominal Wall Hernia
23%
Risk Communication
23%
Serine
23%
MAPK Signaling
23%
Pembrolizumab
23%
Phosphotransferase
23%
Cytochrome C Oxidase
23%
Akt/mTOR Signaling
23%
Cross-Validation
23%
Cancer Risk
23%
Patient with Leukemia
23%
Melanocytic Nevus
23%
Mitogen-Activated Protein Kinase
23%
Retinol
23%
Gastrointestinal Tract
23%
Sebaceous Cyst
23%
Lumpectomy
23%
Colon Tumor
23%
Keyphrases
Tumor
30%
Stage IV Melanoma
29%
Colon Adenocarcinoma
28%
Apoptosis
28%
Bile Salts
25%
Neoadjuvant
23%
Tumor Promoter
23%
Ductal Carcinoma in Situ
23%
Local Treatment
23%
Recurrence Rate
23%
Poly(ADP-ribose) Polymerase
23%
Complications of Laparoscopic Cholecystectomy
23%
Non-palpable Breast Lesions
23%
Subhepatic Appendicitis
23%
Breast Cancer Susceptibility Gene 1 (BRCA1)
23%
Apoptotic Index
23%
Stress Proteins
23%
Notch1
23%
Intestinal Malrotation
23%
Malrotation
23%
YpN0
23%
INPP5A
23%
Cutaneous Squamous Cell Carcinoma (cSCC)
23%
Inositol Phosphatase
23%
Abdominal Hernia
23%
Cyclooxygenase-1 (COX-1)
23%
Sphincter-saving Resection
23%
Computational Histopathology
23%
Pembrolizumab
23%
Topical Diclofenac
23%
NF-B
23%
Salt-induced
23%
Immunohistochemical Markers
23%
Deoxycholate
23%
Cell Loss
23%
DNA Damage
23%
Expression Level
23%
Melanocytic Nevus
23%
Protein Pathway Activation Mapping
23%
Multifunctional Protein
23%
Healthy Skin
23%
Transpyloric
23%
Gluteal Region
23%
Epidermal Inclusion Cyst
23%
Epidermal Cyst
23%
Colon Tumor
23%
Induced Apoptosis
23%
Tumor DNA
23%
Difluoromethyl
23%
Advanced Melanoma
23%
